WallStreetZenWallStreetZen

NASDAQ: GNLX
Genelux Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their GNLX stock forecasts and price targets.

Forecast return on equity

Is GNLX forecast to generate an efficient return?

Company
203.36%
Industry
24.33%
Market
180.2%
GNLX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GNLX forecast to generate an efficient return on assets?

Company
125.04%
Industry
23.56%
GNLX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GNLX earnings per share forecast

What is GNLX's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$0.82
Avg 2 year Forecast
-$0.76
Avg 3 year Forecast
-$0.16

GNLX revenue forecast

What is GNLX's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$13.8M
Avg 3 year Forecast
$90.1M

GNLX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GNLX$1.98N/AN/A
TNXP$5.13$24.00+367.84%Strong Buy
MIST$0.70$6.00+753.49%Strong Buy
RLYB$16.40N/AN/A
TNYA$0.39N/AN/A
View Top Biotech Stocks

Genelux Stock Forecast FAQ

What is GNLX's earnings growth forecast for 2026-2028?

(NASDAQ: GNLX) Genelux's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.7%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.78%.

Genelux's earnings in 2026 is -$35,596,000.On average, 7 Wall Street analysts forecast GNLX's earnings for 2026 to be -$37,196,190, with the lowest GNLX earnings forecast at -$37,689,364, and the highest GNLX earnings forecast at -$36,580,853. On average, 7 Wall Street analysts forecast GNLX's earnings for 2027 to be -$34,241,670, with the lowest GNLX earnings forecast at -$40,793,194, and the highest GNLX earnings forecast at -$26,604,257.

In 2028, GNLX is forecast to generate -$7,076,370 in earnings, with the lowest earnings forecast at -$43,897,024 and the highest earnings forecast at $28,979,637.

If you're new to stock investing, here's how to buy Genelux stock.

What is GNLX's revenue growth forecast for 2026-2028?

(NASDAQ: GNLX) Genelux's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.09%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.2%.

Genelux's revenue in 2026 is $0.On average, 7 Wall Street analysts forecast GNLX's revenue for 2026 to be $0, with the lowest GNLX revenue forecast at $0, and the highest GNLX revenue forecast at $0. On average, 7 Wall Street analysts forecast GNLX's revenue for 2027 to be $625,969,210, with the lowest GNLX revenue forecast at $523,217,054, and the highest GNLX revenue forecast at $802,516,507.

In 2028, GNLX is forecast to generate $4,078,595,478 in revenue, with the lowest revenue forecast at $2,406,599,369 and the highest revenue forecast at $6,670,067,286.

What is GNLX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: GNLX) forecast ROA is 125.04%, which is higher than the forecast US Biotechnology industry average of 23.56%.

What is GNLX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: GNLX) Genelux's current Earnings Per Share (EPS) is -$0.86. On average, analysts forecast that GNLX's EPS will be -$0.82 for 2026, with the lowest EPS forecast at -$0.83, and the highest EPS forecast at -$0.81. On average, analysts forecast that GNLX's EPS will be -$0.76 for 2027, with the lowest EPS forecast at -$0.90, and the highest EPS forecast at -$0.59. In 2028, GNLX's EPS is forecast to hit -$0.16 (min: -$0.97, max: $0.64).

What is GNLX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: GNLX) forecast ROE is 203.36%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.